Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Werner

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Infectious Diseases|November 17, 1998
Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infectionJ A DesJardin, L Gibbons, E Cho, et al.
The American Journal of Medicine|August 1, 1997
The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, MarylandM J George, D R Snydman, B G Werner, et al.
American Journal of Obstetrics and Gynecology|September 1, 1992
Seroprevalence of human immunodeficiency virus in parturients at Boston City Hospital: implications for public health and obstetric practiceS P Donegan, K A Steger, L Recla, et al.
Lancet (London, England)|July 30, 1977
Hepatitis-B virus in bedbugs (Cimex hemipterus) from SenegalW Wills, B Larouzé, W T London, et al.
The Journal of Pediatrics|February 1, 1993
Interference of immune globulin with measles and rubella immunizationG R Siber, B G Werner, N A Halsey, et al.
Transplantation|June 15, 1997
Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipientsM E Falagas, M Arbo, R Ruthazer, et al.
Transplantation Proceedings|October 1, 1994
A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study GroupD R Snydman, B G Werner, N N Dougherty, et al.
Transplantation Proceedings|October 1, 1993
Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG-Study GroupM J George, D R Snydman, B G Werner, et al.
Transplantation|November 1, 1984
A pilot trial of a novel cytomegalovirus immune globulin in renal transplant recipientsD R Snydman, J McIver, J Leszczynski, et al.
Transplantation|November 10, 1998
Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysisM E Falagas, C Paya, R Ruthazer, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|November 17, 1998
Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infectionJ A DesJardin, L Gibbons, E Cho, et al.
The American Journal of Medicine|August 1, 1997
The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, MarylandM J George, D R Snydman, B G Werner, et al.
American Journal of Obstetrics and Gynecology|September 1, 1992
Seroprevalence of human immunodeficiency virus in parturients at Boston City Hospital: implications for public health and obstetric practiceS P Donegan, K A Steger, L Recla, et al.
Lancet (London, England)|July 30, 1977
Hepatitis-B virus in bedbugs (Cimex hemipterus) from SenegalW Wills, B Larouzé, W T London, et al.
The Journal of Pediatrics|February 1, 1993
Interference of immune globulin with measles and rubella immunizationG R Siber, B G Werner, N A Halsey, et al.
Transplantation|June 15, 1997
Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipientsM E Falagas, M Arbo, R Ruthazer, et al.
Transplantation Proceedings|October 1, 1994
A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study GroupD R Snydman, B G Werner, N N Dougherty, et al.
Transplantation Proceedings|October 1, 1993
Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG-Study GroupM J George, D R Snydman, B G Werner, et al.
Transplantation|November 1, 1984
A pilot trial of a novel cytomegalovirus immune globulin in renal transplant recipientsD R Snydman, J McIver, J Leszczynski, et al.
Transplantation|November 10, 1998
Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysisM E Falagas, C Paya, R Ruthazer, et al.
Pageof 6